Literature DB >> 16716807

Differences in CXCR4-mediated signaling in B cells.

Elena Palmesino1, Barbara Moepps, Peter Gierschik, Marcus Thelen.   

Abstract

Among all chemokine receptors CXCR4 possesses a unique response profile and distinguishes itself through a prolonged signaling capacity. Here, we investigated the signaling capacity of CXCR4 to its so far known unique ligand CXCL12 in B cell lines and primary CD19(+) B lymphocytes. During lymphopoiesis, CXCR4 is continuously expressed on the surface of B cells. However, its signaling profile changes inasmuch preB and proB cells migrate towards CXCL12, mobilize intracellular calcium and activate the small GTPases Rac1 and Cdc42, whereas mature B cells do not show these responses, albeit the cells retain the capability to migrate in response to CXCL13 and CCL21. By contrast, stimulation of B cells with CXCL12 at all stages of development results in the activation of the MAP-kinase cascade and in rapid CXCR4 internalization. The pathways leading to ERK1/2 activation are different in preB and mature B cell lines. In either case, ERK1/2 activation is pertussis toxin sensitive, but only in mature B-cells inhibition of PI3-kinase causes an almost complete block of ERK1/2 activation. Taken together, the results show that CXCR4 changes its coupling to downstream signal-transduction pathways in B cells, suggesting that receptor activity may depend on accessory proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716807     DOI: 10.1016/j.imbio.2005.12.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  14 in total

Review 1.  CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target.

Authors:  Aparecida de Lourdes Perim; Marla Karine Amarante; Roberta Losi Guembarovski; Carlos Eduardo Coral de Oliveira; Maria Angelica Ehara Watanabe
Journal:  Cell Mol Life Sci       Date:  2015-01-09       Impact factor: 9.261

2.  Generation and characterization of novel local and metastatic human neuroblastoma variants.

Authors:  Ido Nevo; Orit Sagi-Assif; Liat Edry Botzer; Dana Amar; Shelly Maman; Naam Kariv; Leonor E Leider-Trejo; Larissa Savelyeva; Manfred Schwab; Ilana Yron; Isaac P Witz
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

3.  LPS-induced migration of peritoneal B-1 cells is associated with upregulation of CXCR4 and increased migratory sensitivity to CXCL12.

Authors:  Hana Moon; Jae-Ghi Lee; Sang Hyuck Shin; Tae Jin Kim
Journal:  J Korean Med Sci       Date:  2011-12-19       Impact factor: 2.153

4.  Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.

Authors:  Janette Furuzawa-Carballeda; Gabriela Hernández-Molina; Guadalupe Lima; Yahaira Rivera-Vicencio; Karen Férez-Blando; Luis Llorente
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

5.  Molecular cloning, characterization, and expression analysis of the CXCR4 gene from Turbot: Scophthalmus maximus.

Authors:  Airong Jia; Xiao-Hua Zhang
Journal:  J Biomed Biotechnol       Date:  2009-09-08

6.  Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus.

Authors:  Vincent Biajoux; Alexandre Bignon; Christelle Freitas; Valérie Martinez; Marcus Thelen; Guadalupe Lima; Juan Jakez-Ocampo; Dominique Emilie; Luis Llorente; Karl Balabanian
Journal:  J Transl Med       Date:  2012-12-18       Impact factor: 5.531

7.  Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study.

Authors:  Janette Furuzawa-Carballeda; Guadalupe Lima; Perla Simancas; Dolores Ramos-Bello; Margaret Simancas; Ian C Bostock; Mario Vilatobá; Bernardo Gabilondo; Julio Granados; Luis Morales-Buenrostro; Josefina Alberú; Luis Llorente
Journal:  J Transplant       Date:  2012-11-19

Review 8.  Multiple levels of chemokine receptor regulation in the control of mouse natural killer cell development.

Authors:  Giovanni Bernardini; Giorgia Benigni; Fabrizio Antonangeli; Andrea Ponzetta; Angela Santoni
Journal:  Front Immunol       Date:  2014-02-13       Impact factor: 7.561

9.  Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck.

Authors:  Jan Boucek; Tomas Mrkvan; Martin Chovanec; Martin Kuchar; Jaroslav Betka; Vladimir Boucek; Marie Hladikova; Jan Betka; Tomas Eckschlager; Blanka Rihova
Journal:  J Cell Mol Med       Date:  2009-01-14       Impact factor: 5.310

10.  The analysis of heterotaxy patients reveals new loss-of-function variants of GRK5.

Authors:  Davor Lessel; Tariq Muhammad; Teresa Casar Tena; Barbara Moepps; Martin D Burkhalter; Marc-Phillip Hitz; Okan Toka; Axel Rentzsch; Stephan Schubert; Adelheid Schalinski; Ulrike M M Bauer; Christian Kubisch; Stephanie M Ware; Melanie Philipp
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.